 For patients with 1-6 intraparenchymal brain metastases from various primary histologies except for melanoma, stereotactic radiosurgery administered upfront or concurrently or complete surgical resection with neural stem cell NSC-preserving whole-brain radiotherapy WBRT results in improved neurocognitive profile over standard WBRT. The goal of this study is to assess feasibility of this treatment approach. 